Research Article
Antimicrobial Resistance Profiles for Different Isolates in Aden, Yemen: A Cross-Sectional Study in a Resource-Poor Setting
Table 3
Bacterial resistance patterns to the selected antibiotics.
| | Type of isolate | Antimicrobial nonsusceptibility | | Amoxicillin with clavulanate /total (%) | Ampicillin with sulbactam /total (%) | Azithromycin /total (%) | Cefepime /total (%) | Cefotaxime /total (%) | Cefoxitin /total (%) | Ceftriaxone /total (%) | | Klebsiella species | 5/8 (62.50) | 0/1(0) | 2/6 (33.33) | 5/7 (71.43) | 2/6 (33.33) | 1/4 (25.00) | 0/3 (0) | | E. coli | 71/98 (72.40) | 8/20 (40.00) | 7/23 (30.43) | 61/89 (68.54) | 76/111 (68.47) | 23/85 (27.05) | 77/114 (32.45) | | Pseudomonas species | 24/27 (88.88) | 4/5 (80.00) | 1/9 (11.11) | 14/24 (58.33) | 7/7 (100) | 6/8 (75.00) | 9/13 (69.23) | | Staphylococcus aureus | 10/16 (62.50) | 1/31 (3.22) | 27/85 (31.76) | 20/33 (60.60) | 14/29 (48.27) | 12/65 (18.46) | 17/33 (51.51) | | Streptococcus species | 6/29 (20.68) | 1/31 (3.22) | 0/1 (0) | 2/3 (66.66) | 1/3 (33.33) | ND | 1/2 (50.00) | | Proteus species | 1/2 (50.00) | ND | 1/2 (50.00) | 0/3 (0) | 0/4 (0) | 1/2 (50.00) | 0/2 (0) | | Enterobacter species | 1/1 (100) | ND | 0/1 (0) | 1/1 (100) | 3/3 (100) | 0/1 (0) | ND | | Enterococcus species | ND | ND | ND | ND | 1/1 (100) | ND | ND | | Salmonella Paratyphi A | ND | ND | ND | ND | 1/1 (100) | ND | 2/3 (66.66) | | Sphingomonas paucimobilis | ND | ND | ND | 1/1 (100) | 0/1 (0) | 1/1 (100) | ND | | Total | 118/181 (65.19) | 21/97 (21.65) | 38/127 (29.92) | 104/161 (64.60) | 104/166 (62.65) | 44/166 (26.50) | 107/172 (62.20) |
| | Type of isolate | Antimicrobial nonsusceptibility | | Ciprofloxacin /total (%) | Ceftazidime /total (%) | Cefuroxime /Total (%) | Ertapenem /total (%) | Gentamycin /total (%) | Levofloxacin /total (%) | Sulfamethoxazole with trimethoprim /total (%) | | Klebsiella species | 5/12 (41.66) | 1/3 (33.33) | 4/5 (80.0) | 1/5 (20.0) | 5/8 (62.50) | 0/1 (0) | 2/3 (66.66) | | E. coli | 28/103 (27.18) | 12/29 (41.38) | 19/26 (73.07) | 6/89 (93.25) | 9/23 (39.13) | 11/40 (27.5) | 57/75 (76.0) | | Pseudomonas species | 10/28 (35.71) | 8/17 (47.05) | 14/19 (73.68) | 3/4 (74.0) | 5/16 (31.25) | 0/13 (0) | 9/15 (60.0) | | Staphylococcus aureus | 19/95 (20.0) | 7/11 (63.63) | 15/45 (33.33) | 9/17 (52.94) | 12/45 (26.66) | 9/73 (12.32) | 49/66 (74.24) | | Streptococcus species | ND | ND | 1/2 (50.0) | 1/2 (50.0) | 0/1 (0) | ND | 0/1 (0) | | Proteus species | 0/1 (0) | ND | 1/2 (50.0) | 0/2 (0) | 0/1 (0) | 0/2 (0) | ND | | Enterobacter species | 1/5 (20.0) | 1/1 (100) | 1/1 (100) | 0/1 (0) | 0/1 (0) | 1/2 (50.0) | ND | | Enterococci species | ND | ND | 0/1 (0) | ND | 1/2 (50.0) | 0/2 (0) | ND | | Salmonella Paratyphi A | 0/1 (0) | ND | 1/2 (50.0) | ND | ND | 0/2 (0) | ND | | Sphingomonas paucimobilis | 0/1 | ND | ND | ND | 0/1 (0) | ND | ND | | Total | 63/246 (25.60) | 29/61 (47.54) | 56/103 (54.36) | 20/120 (16.67) | 32/98 (32.65) | 21/135 (15.56) | 117/160 (73.13) |
|
|
